(Reuters) - Insys Therapeutics on Thursday posted a quarterly loss that was bigger than analysts' expectations, as it faced soft demand for its flagship opioid painkiller Subsys, which is at the center of a federal probe at the company.
from Reuters: Business News http://ift.tt/2iXLzzS
from Reuters: Business News http://ift.tt/2iXLzzS
Insys posts bigger loss amid bribery probe of founder
![Insys posts bigger loss amid bribery probe of founder]()
Reviewed by Tha Kur
on
November 02, 2017
Rating:
No comments: